SIGNIFY HEALTH INC -CLASS A (SGFY) Fundamental Analysis & Valuation

NYSE:SGFY • US82671G1004

Current stock price

30.49 USD
+0.02 (+0.07%)
At close:
30.49 USD
0 (0%)
After Hours:

This SGFY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SGFY Profitability Analysis

1.1 Basic Checks

  • SGFY had negative earnings in the past year.
  • In the past year SGFY had a positive cash flow from operations.
SGFY Yearly Net Income VS EBIT VS OCF VS FCFSGFY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 -200M -400M

1.2 Ratios

  • The profitability ratios for SGFY are negative, so there is not much use analyzing them.
  • The Return On Invested Capital of SGFY (6.14%) is better than 67.26% of its industry peers.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 6.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGFY Yearly ROA, ROE, ROICSGFY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -20 -40 -60 -80

1.3 Margins

  • The Operating Margin of SGFY (13.53%) is better than 89.38% of its industry peers.
  • SGFY's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 45.33%, SGFY is in the better half of the industry, outperforming 72.57% of the companies in the same industry.
  • SGFY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.53%
PM (TTM) N/A
GM 45.33%
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
SGFY Yearly Profit, Operating, Gross MarginsSGFY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 20 -20 40 -40 -60

4

2. SGFY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SGFY is destroying value.
  • The number of shares outstanding for SGFY has been increased compared to 1 year ago.
  • The debt/assets ratio for SGFY is higher compared to a year ago.
SGFY Yearly Shares OutstandingSGFY Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 50M 100M 150M 200M
SGFY Yearly Total Debt VS Total AssetsSGFY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 3.36 indicates that SGFY is not in any danger for bankruptcy at the moment.
  • SGFY has a better Altman-Z score (3.36) than 76.99% of its industry peers.
  • The Debt to FCF ratio of SGFY is 93.50, which is on the high side as it means it would take SGFY, 93.50 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 93.50, SGFY is in line with its industry, outperforming 52.21% of the companies in the same industry.
  • SGFY has a Debt/Equity ratio of 0.53. This is a neutral value indicating SGFY is somewhat dependend on debt financing.
  • SGFY has a better Debt to Equity ratio (0.53) than 60.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 93.5
Altman-Z 3.36
ROIC/WACC0.66
WACC9.37%
SGFY Yearly LT Debt VS Equity VS FCFSGFY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.62 indicates that SGFY should not have too much problems paying its short term obligations.
  • SGFY's Current ratio of 1.62 is fine compared to the rest of the industry. SGFY outperforms 67.26% of its industry peers.
  • A Quick Ratio of 1.62 indicates that SGFY should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.62, SGFY is doing good in the industry, outperforming 72.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
SGFY Yearly Current Assets VS Current LiabilitesSGFY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

5

3. SGFY Growth Analysis

3.1 Past

  • SGFY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -390.91%.
  • SGFY shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.33%.
  • SGFY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.09% yearly.
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%

3.2 Future

  • SGFY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 93.52% yearly.
  • Based on estimates for the next years, SGFY will show a quite strong growth in Revenue. The Revenue will grow by 18.33% on average per year.
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SGFY Yearly Revenue VS EstimatesSGFY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
SGFY Yearly EPS VS EstimatesSGFY Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 0 -1 -2

3

4. SGFY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SGFY. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 94.60 indicates a quite expensive valuation of SGFY.
  • SGFY's Price/Forward Earnings ratio is in line with the industry average.
  • SGFY is valuated expensively when we compare the Price/Forward Earnings ratio to 21.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 94.6
SGFY Price Earnings VS Forward Price EarningsSGFY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as SGFY.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as SGFY.
Industry RankSector Rank
P/FCF 1516.44
EV/EBITDA 32.74
SGFY Per share dataSGFY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • SGFY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SGFY's earnings are expected to grow with 93.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y93.52%
EPS Next 3YN/A

2

5. SGFY Dividend Analysis

5.1 Amount

  • SGFY has a Yearly Dividend Yield of 1.26%.
  • SGFY's Dividend Yield is rather good when compared to the industry average which is at 0.45. SGFY pays more dividend than 85.84% of the companies in the same industry.
  • SGFY's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

  • SGFY does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y93.52%
EPS Next 3YN/A
SGFY Yearly Income VS Free CF VS DividendSGFY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 0 -200M -400M

SGFY Fundamentals: All Metrics, Ratios and Statistics

SIGNIFY HEALTH INC -CLASS A

NYSE:SGFY (3/28/2023, 8:04:01 PM)

After market: 30.49 0 (0%)

30.49

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength49.07
Industry Growth88.82
Earnings (Last)03-07
Earnings (Next)05-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.46%
Ins Owner Change0%
Market Cap5.46B
Revenue(TTM)805.50M
Net Income(TTM)-576.80M
Analysts70
Price Target30.01 (-1.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-788.65%
Min EPS beat(2)-1114.2%
Max EPS beat(2)-463.11%
EPS beat(4)1
Avg EPS beat(4)-261.16%
Min EPS beat(4)-1114.2%
Max EPS beat(4)761.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.89%
Min Revenue beat(2)-42.43%
Max Revenue beat(2)-11.35%
Revenue beat(4)0
Avg Revenue beat(4)-14.07%
Min Revenue beat(4)-42.43%
Max Revenue beat(4)-0.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 94.6
P/S 6.78
P/FCF 1516.44
P/OCF 171.13
P/B 8.7
P/tB N/A
EV/EBITDA 32.74
EPS(TTM)-0.32
EYN/A
EPS(NY)0.32
Fwd EY1.06%
FCF(TTM)0.02
FCFY0.07%
OCF(TTM)0.18
OCFY0.58%
SpS4.5
BVpS3.5
TBVpS-0.9
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 6.14%
ROICexc 9.77%
ROICexgc N/A
OM 13.53%
PM (TTM) N/A
GM 45.33%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)5.48%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y104.84%
ROICexc growth 5YN/A
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 93.5
Debt/EBITDA 2.07
Cap/Depr 52.6%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z 3.36
F-Score3
WACC9.37%
ROIC/WACC0.66
Cap/Depr(3y)53.08%
Cap/Depr(5y)45.67%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
EBIT growth 1Y26.74%
EBIT growth 3Y75.98%
EBIT growth 5YN/A
EBIT Next Year153.12%
EBIT Next 3Y41%
EBIT Next 5Y25.5%
FCF growth 1Y-96.67%
FCF growth 3Y-39.43%
FCF growth 5YN/A
OCF growth 1Y-75.44%
OCF growth 3Y-8.54%
OCF growth 5YN/A

SIGNIFY HEALTH INC -CLASS A / SGFY Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SIGNIFY HEALTH INC -CLASS A?

ChartMill assigns a fundamental rating of 4 / 10 to SGFY.


Can you provide the valuation status for SIGNIFY HEALTH INC -CLASS A?

ChartMill assigns a valuation rating of 3 / 10 to SIGNIFY HEALTH INC -CLASS A (SGFY). This can be considered as Overvalued.


How profitable is SIGNIFY HEALTH INC -CLASS A (SGFY) stock?

SIGNIFY HEALTH INC -CLASS A (SGFY) has a profitability rating of 1 / 10.


What is the financial health of SIGNIFY HEALTH INC -CLASS A (SGFY) stock?

The financial health rating of SIGNIFY HEALTH INC -CLASS A (SGFY) is 6 / 10.